News
FDA asks mRNA vaccine makers to widen age range for rare heart risk warning
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA vaccines to widen the age range of boys and young men that their labels say are at risk for a rare side effect causing heart inflammation.
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines and treatments, why are people still dying?
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
Zacks Investment Research on MSN1d
MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo ShotShares of Moderna MRNA declined nearly 8% yesterday after it announced that it had voluntarily withdrawn a regulatory filing ...
KFF Health News on MSN1d
Trump’s Team Cited Safety in Limiting Covid Shots. Patients, Health Advocates See More Risk.The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.
Live Science on MSN4d
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback